세계의 저체온 치료 시스템 시장 : 제품별(냉각 장치, 냉각 카테터, 쿨캡), 용도별(신경과, 순환기내과, 신생아 치료), 지역별 - 예측(-2028년)
Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028
상품코드:1415820
리서치사:MarketsandMarkets
발행일:2024년 01월
페이지 정보:영문 168 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
조사 범위
조사 대상년도
2021년-2028년
기준년도
2022년
예측 기간
2023년-2028년
검토 단위
금액(100만 달러)
부문
제품별, 용도별, 최종사용자별
대상 지역
북미, 유럽, 아시아태평양 및 기타 지역
세계 저체온증 치료 시스템 시장 규모는 예측 기간 동안 CAGR 6.3%로 확대되어 2023년 2억 9,100만 달러에서 2028년 3억 9,600만 달러에 달할 것으로 예상됩니다.
시장 성장의 주요 원동력은 감염 및 만성 질환의 유병률 증가와 저침습적 냉각 방법의 사용 증가입니다. 그러나 대체 방법의 존재와 개발도상국에서의 낮은 인지도는 치료용 저체온 시스템 시장의 성장을 저해할 수 있습니다.
제품별로는 2022년 냉각 장치 부문이 시장을 주도했습니다. 이 부문의 큰 점유율은 사용 편의성, 사용 가능한 노동 집약적 인 장치가 적고 제어 장치를 통한 간단하고 효과적인 온도 조절 시스템의 존재에 기인합니다.
용도별로는 2022년 저체온 치료 시스템 시장에서 가장 높은 CAGR을 기록한 분야는 순환기 분야였습니다. 이 부문의 CAGR이 가장 높은 이유는 주로 심정지 환자 치료에 저체온 요법을 사용하는 것이 잠재적인 이점이 있기 때문입니다.
지역별로 보면, 북미는 예측 기간 동안 높은 시장 점유율을 차지할 것으로 예상됩니다. 기술적으로 진보된 치료용 저체온 시스템 제품의 존재와 의료기기 산업의 발전이 증가하면서 치료용 저체온 시스템 시장의 성장을 뒷받침하고 있습니다.
이 보고서는 세계 저체온증 치료 시스템 시장을 조사했으며, 제품별/용도별/최종사용자별/지역별 동향과 시장 진출기업 프로파일 등을 정리한 보고서입니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 프리미엄 인사이트
제5장 시장 개요
서론
시장 역학
밸류체인 분석
공급망 분석
Porter의 Five Forces 분석
규제 분석
무역 분석
기술 분석
생태계 분석
특허 분석
2024년-2025년 주요 컨퍼런스 및 이벤트
가격 분석
고객의 비즈니스에 영향을 미치는 동향/혼란
주요 이해관계자와 구입 기준
제6장 저체온 치료 시스템 시장, 제품별
서론
냉각 장치
냉각 카테터
쿨캡
제7장 저체온 치료 시스템 시장, 용도별
서론
신경과
순환기과
신생아 케어
기타
제8장 저체온 치료 시스템 시장, 지역별
서론
북미
유럽
아시아태평양
기타 지역
제9장 경쟁 구도
개요
주요 시장 진출기업이 채택한 전략
매출 분석
시장 점유율 분석
기업 평가 매트릭스
스타트업/중소기업 평가 매트릭스
경쟁 시나리오와 동향
제10장 기업 개요
주요 시장 진출기업
ASAHI KASEI CORPORATION(ZOLL MEDICAL CORPORATION)
BECTON, DICKINSON AND COMPANY
GENTHERM INCORPORATED
STRYKER CORPORATION
BELMONT MEDICAL TECHNOLOGIES
INTERNATIONAL BIOMEDICAL LTD.
EM-MED
PHOENIX MEDICAL SYSTEMS
LIFE RECOVERY SYSTEMS
SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
MIRACRADLE(PLUSS ADVANCED TECHNOLOGIES PVT. LTD.)
기타 기업
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
PFM MEDICAL HICO GMBH
VNG MEDICAL INNOVATION SYSTEM PVT. LTD.
ASPEN SYSTEMS
COOLTECH MEDICAL
GLOBAL HEALTHCARE SG
CRYOTHERMIC SYSTEMS INCORPORATED
PAXMAN COOLERS LTD.
DIGNITANA AB
WISHCAPS
제11장 부록
LSH
영문 목차
영문목차
Report Description
Scope of the Report
Years Considered for the Study
2021-2028
Base Year
2022
Forecast Period
2023-2028
Units Considered
Value (USD) Million
Segments
Product, Application, and End User
Regions covered
North America, Europe, Asia Pacific, Rest of the World
The global therapeutic hypothermia systems market is projected to reach USD 396 million by 2028 from USD 291 million in 2023, at a CAGR of 6.3% during the forecast period. The growth of this market is majorly driven by the growing prevalence of infectious and chronic diseases and the rise in the use of minimally invasive cooling methods. However, the presence of alternative methods and less awareness in developing countries could restrain the growth of the therapeutic hypothermia systems market.
"Cooling devices segment accounted for the highest market share in the therapeutic hypothermia systems market, by product, during the forecast period."
Based on product, the therapeutic hypothermia systems market is classified into Cooling Catheters, Cooling devices and Cool Caps. The cooling devices segment dominated the market in 2022. The large share of the segment can be attributed to the ease of use, fewer labor-intensive devices available, and the presence of a simple and effective thermal regulating system with the control unit.
"Cardiology accounted for the highest CAGR during the forecast period."
Based on the application, the therapeutic hypothermia systems market is segmented into Neurology, Cardiology, Neonatal care, and other applications. The cardiology segment accounted for the highest CAGR of the therapeutic hypothermia systems market in 2022. The highest CAGR of this segment can be primarily attributed to the potential benefit of using hypothermia for treating cardiac arrest patients.
"The North America segment accounted for the highest market share in the therapeutic hypothermia systems market, by region, during the forecast period."
Based on the region, the global therapeutic hypothermia systems market is categorized into North America, Asia Pacific, Europe, and the Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced therapeutic hypothermia systems products and the increasing advancement in the medical device industries are supporting the growth of the therapeutic hypothermia systems market.
Breakdown of supply-side primary interviews by company type, designation, and region:
By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
By Designation: C-level (28%), Director-level (33%), and Others (39%)
By Region: North America (21%), Europe (30%), Asia-Pacific (34%), and RoW (15%)
Prominent companies include ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), Gentherm Incorporated (US), Belmont Medical Technologies (US), International Biomedical Ltd. (US), EM-MED (Poland), Phoenix Medical Systems (India), Life Recovery Systems (US), Shenzhen Comen Medical Instruments Co., Ltd. (China), MiraCradle (India), Terumo Cardiovascular Systems Corporation (US), pfm medical hico gmbh (Germany), VNG Medical Innovation System Pvt. Ltd. (India), Aspen Systems (US), CoolTech Medical (US), Global Healthcare SG (Singapore), Cryothermic Systems Incorporated (US), Paxman Coolers Ltd. (UK), Dignitana AB (Italy), and Wishcaps (US).
Research Coverage
This research report categorizes the therapeutic hypothermia systems market by product, application, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the therapeutic hypothermia systems market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the therapeutic hypothermia systems market. Competitive analysis of upcoming startups in the therapeutic hypothermia systems market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall therapeutic hypothermia systems market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the therapeutic hypothermia systems market
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the therapeutic hypothermia systems market.
Market Development: Comprehensive information about lucrative markets - the report analyses the therapeutic hypothermia systems market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the therapeutic hypothermia systems market
Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), among others in the therapeutic hypothermia systems market strategies.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
2.2.2 APPROACH 2: NUMBER OF THERAPEUTIC HYPOTHERMIA SYSTEMS
TABLE 1 REVENUE ESTIMATION APPROACH BY CALCULATING MARKET SIZE OF THERAPEUTIC HYPOTHERMIA SYSTEMS
2.2.3 APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
2.2.4 APPROACH 4: PRIMARY INTERVIEWS
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 MARKET ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT
2.7 RECESSION IMPACT ON THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
3 EXECUTIVE SUMMARY
FIGURE 10 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
4 PREMIUM INSIGHTS
4.1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET OVERVIEW
FIGURE 13 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
4.2 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 14 COOLING DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: REGIONAL MIX
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
4.5 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising population and increasing prevalence of chronic and infectious diseases
5.2.1.2 Increasing number of surgical procedures
5.2.1.3 Rising number of hypothermia cases
5.2.1.4 Growing number of trauma cases
5.2.1.5 Rising adoption of minimally invasive cooling methods
5.2.1.6 Growing demand for targeted temperature management in cardiac arrest
5.2.2 RESTRAINTS
5.2.2.1 Lack of awareness regarding therapeutic hypothermia systems in developing countries
5.2.2.2 Availability of alternative methods
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing growth opportunities in emerging economies
5.2.3.2 Developing healthcare infrastructure
5.2.3.3 Growing number of contracts and agreements between market players
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled healthcare professionals
5.2.4.2 Lack of proper supply chain management
5.2.4.3 Product recalls
5.3 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 20 DISTRIBUTION-STRATEGY PREFERRED BY PROMINENT COMPANIES
5.5 PORTER'S FIVE FORCES ANALYSIS
TABLE 3 PORTER'S FIVE FORCES ANALYSIS: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 THREAT OF NEW ENTRANTS
5.6 REGULATORY ANALYSIS
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THERAPEUTIC HYPOTHERMIA SYSTEMS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
FIGURE 21 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
5.6.1.2 Canada
FIGURE 22 CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 23 CE APPROVAL PROCESS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.2 China
TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION
5.6.3.3 India
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018-2022 (USD MILLION)
TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018-2022 (USD MILLION)
5.8 TECHNOLOGY ANALYSIS
5.9 ECOSYSTEM ANALYSIS
FIGURE 24 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: ECOSYSTEM ANALYSIS
5.9.1 ROLE IN ECOSYSTEM
FIGURE 25 KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS ECOSYSTEM
5.10 PATENT ANALYSIS
FIGURE 26 PATENT ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.11 KEY CONFERENCES AND EVENTS IN 2024-2025
TABLE 10 LIST OF CONFERENCES AND EVENTS IN 2024-2025
5.12 PRICING ANALYSIS
TABLE 11 AVERAGE SELLING PRICE OF KEY PRODUCTS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET (2019-2022)
TABLE 12 AVERAGE SELLING PRICE TRENDS, BY REGION, 2019-2022
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR THERAPEUTIC HYPOTHERMIA SYSTEM MANUFACTURERS
FIGURE 27 REVENUE SHIFT FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
5.14.2 BUYING CRITERIA
FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS
TABLE 14 KEY BUYING CRITERIA, BY TOP END USER
6 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 15 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
6.2 COOLING DEVICES
6.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE DEMAND
TABLE 123 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY OVERVIEW
10.2.2 PFM MEDICAL HICO GMBH
TABLE 124 PFM MEDICAL HICO GMBH: COMPANY OVERVIEW
10.2.3 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.
TABLE 125 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.: COMPANY OVERVIEW
10.2.4 ASPEN SYSTEMS
TABLE 126 ASPEN SYSTEMS: COMPANY OVERVIEW
10.2.5 COOLTECH MEDICAL
TABLE 127 COOLTECH MEDICAL: COMPANY OVERVIEW
10.2.6 GLOBAL HEALTHCARE SG
TABLE 128 GLOBAL HEALTHCARE SG: COMPANY OVERVIEW
10.2.7 CRYOTHERMIC SYSTEMS INCORPORATED
TABLE 129 CRYOTHERMIC SYSTEMS INCORPORATED: COMPANY OVERVIEW
10.2.8 PAXMAN COOLERS LTD.
TABLE 130 PAXMAN COOLERS LTD.: COMPANY OVERVIEW
10.2.9 DIGNITANA AB
TABLE 131 DIGNITANA AB: COMPANY OVERVIEW
10.2.10 WISHCAPS
TABLE 132 WISHCAPS: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
